yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26851202-BC3B3452-7E58-4CD3-8AAB-3167B9BB3E69
Q26851202-BC3B3452-7E58-4CD3-8AAB-3167B9BB3E69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851202-BC3B3452-7E58-4CD3-8AAB-3167B9BB3E69
Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers
P2860
Q26851202-BC3B3452-7E58-4CD3-8AAB-3167B9BB3E69
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851202-BC3B3452-7E58-4CD3-8AAB-3167B9BB3E69
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f43d0812f4314feda5f778d0fe02a0c3b7b39cc
P2860
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.